Answers are grounded in this paper and cite their sources.
// Jin Gu Cho 1, 2 , Seho Park 3 , Chae Hyun Lim 4 , Hong Sook Kim 2 , Seung Yong Song 5 , Tae-Young Roh 4 , Jong-Hyuk Sung 6 , Wonhee Suh 7 , Seok-Jin Ham 4 , Key-Hwan Lim 2 , Sang Gyu Park 2 1 Department of Biomedical Science, CHA University, Sungnam-si, Gyunggi-do, Korea 2 Laboratory for Tracing of Gene Function, Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, Gyunggi-do, Korea 3 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea 4 Division of Integrative Biosciences & Biotechnology, Pohang University of Science & Technology (POSTECH), Pohang, Gyeongbuk, Korea 5 Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine, Seoul, Korea 6 Department of Pharmacy, College of Pharmacy, Yonsei University, Incheon, Korea 7 Department of Pharmacy, College of Pharmacy, Chung-Ang University, Seoul, Korea Correspondence to: Sang Gyu Park, e-mail: sgpark@ajou.ac.kr Keywords: ZNF224, miR-663a, p53, p21, apoptosis Received: December 22, 2015 Accepted: March 31, 2016 Published: April 20, 2016 ABSTRACT ZNF224 is a Krüppel-associated box-containing zinc-finger protein which represses gene transcription by interacting with various co-repressors. However, its consensus DNA sequences and target genes are not fully identified. In this study, we identified and characterized consensus DNA sequences containing 5‘-CAGC-3’ recognized by ZNF224 through ChIP-sequencing, which further confirmed by ELISA, SPR, qPCR, and luciferase activity assay. ZNF224 increased miR-663a transcription by binding to miR-663a promoter, which in turn binds to 3’ UTR of p53 and p21 to decrease their expression. miR-663a antagonist abolished ZNF224-mediated suppression of p21 and p53, resulting in the enhanced apoptosis by CPT. The analyses using human breast ductal carcinoma tissues exhibited that the expression of ZNF224 and miR-663a was increased in cancer compared to non-cancer region. Consequently, ZNF224 increases cell survival and decreases apoptosis by decreasing the expression of p53 and p21 via miR-663a as a transcriptional activator. Taken together, we identified and characterized DNA binding element of ZNF224, and its target genes, miR-663a, which provides a novel insight in the down-regulation of p21 and p53 via miR-663a by ZNF224 in breast cancer.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: